Trials / Recruiting
RecruitingNCT04262492
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
OBServaToire INternational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Stéphane Zuily · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rivaroxaban | Rivaroxaban 10 mg or 15 mg or 20 mg OD Dabigatran 110 mg or 150 mg BID Apixaban 2.5 mg or 5 mg or 10 mg BID |
Timeline
- Start date
- 2020-10-21
- Primary completion
- 2030-04-01
- Completion
- 2030-04-01
- First posted
- 2020-02-10
- Last updated
- 2024-02-09
Locations
1 site across 1 country: France
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04262492. Inclusion in this directory is not an endorsement.